Testing a proactive expert system intervention to prevent and to quit at-risk alcohol use

Organizational Data

DRKS-ID:
DRKS00014274
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2018-03-12
Last update in DRKS:
2020-04-30
Registration type:
Prospective

Acronym/abbreviation of the study

PRINT

URL of the study

No Entry

Brief summary in lay language

The aim of the PRINT study is to test the efficacy of a brief alcohol intervention using a general population sample (registry office clients). Adults between 18 and 64 years with past year alcohol use are randomly allocated to an intervention group receiving computer-generated individualized feedback letters or an “assessment only” control group. Participants complete four assessments: the baseline assessment, two aftercare assessments at months 3 and 6, and one follow-up assessment at month 12.

Brief summary in scientific language

The PRINT study is a two-arm randomized controlled trial to test the efficacy of a brief alcohol intervention using an adult general population sample. During opening hours, all 18- to 64-year-old registry office clients appearing in the waiting area are approached by study assistants and asked to respond to questions about health risk behaviors. Persons who report alcohol use in the previous twelve months are eligible and asked to participate in the trial. Participants are assigned by tablet PC using a random generator to either the intervention group or the control group (allocation ratio 1:1). Participants in the intervention group receive computer-generated individualized feedback letters and self-help manuals at baseline, month 3, and month 6. Participants in the control group receive minimal assessment only. Twelve-month follow-up assessments are conducted via computer-assisted telephone interviews.

Health condition or problem studied

Free text:
alcohol use
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Intervention group: Participants in the intervention group receive individualized feedback letters and self-help manuals (if appropriate) at baseline, month 3, and month 6. An expert system software (i) analyzes data on alcohol use and motivational constructs in comparison to general population data, (ii) selects supportive text modules and graphics, and (iii) automatically generates feedback letters. The feedback is matched to the motivational stage of change and alcohol use problem severity.
Arm 2:
Control group (assessment only): Participants in the control group receive minimal assessment at baseline, month 3, and month 6, including alcohol use, motivation to change, socio-demographics, and health-related variables.

Endpoints

Primary outcome:
Number of drinks containing alcohol per day (change from baseline to month 12): Quantity-frequency product determined by two questions concerning alcohol use in the month prior to assessment: (1) “In the past 30 days, how often did you have an alcoholic drink?” (never/ once/ 2-4 times/ 2-3 times per week/ 4 or more times per week) and (2) “In the past 30 days, how many drinks did you typically have on a drinking day?”. A drink is defined as 0.25-0.3 l beer, 0.1-0.15 l wine/ sparkling wine, or 4 cl spirits.
Secondary outcome:
a) at-risk alcohol use (change from baseline to month 12): Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score of 4/ 5 or more for women/ men, b) number of heavy drinking days in the past week (change from baseline to month 12) determined by asking “How many drinks did you have on each single day during the past seven days, starting with yesterday?” and summing the days with 4/ 5 or more drinks for women/ men, c) alcohol use problem severity (change from baseline to month 12): AUDIT score, d) motivation to change (change from baseline to month 12): 4-item staging algorithm, e) tobacco use (change from baseline to month 12): quantity-frequency index based on two questions: (1) "On how many days per month did you smoke cigarettes/ cigarillos/ cigars/ pipes?" and (2) "How many cigarettes/ cigarillos/ cigars/ pipes did you typically smoke on a smoking day?". f) mental health (change from baseline to month 12): 5-item mental health inventory (MHI-5), g) self-reported health (change from baseline to month 12): “Would you say your health in general is: excellent/ very good/ good/ fair/ poor?”

Study Design

Purpose:
Prevention
Allocation:
Randomized controlled study
Control:
  • Control group receives no treatment
Phase:
II
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Assessor

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Other Amt für Bürgerservice/ registry office Greifswald

Recruitment period and number of participants

Planned study start date:
2018-04-10
Actual study start date:
2018-04-10
Planned study completion date:
No Entry
Actual Study Completion Date:
2019-07-31
Target Sample Size:
1648
Final Sample Size:
1646

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
64 Years
Additional Inclusion Criteria:
alcohol use in the previous twelve months

Exclusion Criteria

a) cognitively or physically incapable, b) insufficient language or reading skills, c) already approached during an earlier visit, d) escorting person, e) employed at the conducting research Institute, f) no telephone, g) no address

Addresses

Primary Sponsor

Address:
Universitätsmedizin GreifswaldKörperschaft des öffentlichen Rechts
Fleischmannstr. 8
17475 Greifswald
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Technische Universität Dresden, Medizinische Fakultät, Institut und Poliklinik für Arbeits- und Sozialmedizin
Jun.-Prof. Sophie Baumann
Fetscherstr. 74
01307 Dresden
Germany
Telephone:
+49 351 3177-447
Fax:
+49 351 3177-459
Contact per E-Mail:
Contact per E-Mail
URL:
https://tu-dresden.de/med/mf/ipas

Contact for Public Queries

Address:
TU Dresden, Medizinische Fakultät, Institut und Poliklinik für Arbeits- und Sozialmedizin
M.Sc. Psych. Andreas Staudt
Fetscherstraße 74
01307 Dresden
Germany
Telephone:
+493513177452
Fax:
+493513177459
Contact per E-Mail:
Contact per E-Mail
URL:
https://tu-dresden.de/med/mf/ipas

Principal Investigator

Address:
Technische Universität Dresden, Medizinische Fakultät, Institut und Poliklinik für Arbeits- und Sozialmedizin
Jun.-Prof. Sophie Baumann
Fetscherstr. 74
01307 Dresden
Germany
Telephone:
+49 351 3177-447
Fax:
+49 351 3177-459
Contact per E-Mail:
Contact per E-Mail
URL:
https://tu-dresden.de/med/mf/ipas

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Deutsche Forschungsgemeinschaft
Kennedyallee 40
53175 Bonn
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.dfg.de

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission an der Universitätsmedizin Greifswald, Institut für Pharmakologie
Felix-Hausdorff-Straße 3
17487 Greifswald
Germany
Telephone:
+49-3834-865644
Fax:
+49-3834-865631
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2015-10-20
Ethics committee number:
BB 147/15
Vote of the Ethics Committee:
Approved
Date of the vote:
2015-10-28

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
Other secondary IDs:
BA 5858/2-1 - DFG-Förderkennzeichen
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Publication of study results

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry